SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-20-046119
Filing Date
2020-10-08
Accepted
2020-10-08 16:15:56
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 srne-s3.htm S-3 355252
2 EX-5.1 srne-ex51_16.htm EX-5.1 22907
3 EX-23.1 srne-ex231_104.htm EX-23.1 2913
4 GRAPHIC g0pxp1gtqvs2000002.jpg GRAPHIC 3210
5 GRAPHIC gcnpukpave5s000002.jpg GRAPHIC 4769
6 GRAPHIC gcnpukpave5s000001.jpg GRAPHIC 3480
7 GRAPHIC g0pxp1gtqvs2000001.jpg GRAPHIC 3210
8 GRAPHIC gcnpukpave5s000003.jpg GRAPHIC 3025
  Complete submission text file 0001564590-20-046119.txt   407289
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-249386 | Film No.: 201231122
SIC: 2836 Biological Products, (No Diagnostic Substances)